Cargando…
The Protective Effect of a Long-Acting and Multi-Target HM-3-Fc Fusion Protein in Rheumatoid Arthritis
Current treatment of rheumatoid arthritis (RA) is limited by relative shortage of treatment targets. HM-3 is a novel anti-RA polypeptide consisting of 18 amino acids with integrin αVβ3 and α5β1 as targets. Previous studies confirmed that HM-3 effectively inhibited the synovial angiogenesis and the i...
Autores principales: | Huang, Ruijing, Li, Jian, Wang, Yibo, Zhang, Lihua, Ma, Xiaohui, Wang, Hongyu, Li, Wenlei, Cao, Xiaodan, Xu, Hanmei, Hu, Jialiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163367/ https://www.ncbi.nlm.nih.gov/pubmed/30201867 http://dx.doi.org/10.3390/ijms19092683 |
Ejemplares similares
-
Anti-Tumor Activity and Pharmacokinetics of AP25-Fc Fusion Protein
por: Pei, Dening, et al.
Publicado: (2019) -
Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis
por: Hao, Jingchao, et al.
Publicado: (2017) -
OX40-Fc Fusion Protein Alleviates PD-1-Fc-Aggravated Rheumatoid Arthritis by Inhibiting Inflammatory Response
por: Huang, Yanyan, et al.
Publicado: (2022) -
Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis
por: Hu, Jialiang, et al.
Publicado: (2019) -
Retraction Note: Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis
por: Hu, Jialiang, et al.
Publicado: (2020)